Therapeutic drug monitoring

Respiratory Infections: Tuberculosis

17 October 2024 6:00pm–7:30pm

CRE RESPOND Respiratory Infections: Tuberculosis seminar was held Thursday 17 October 2024. Chaired by Dr Andrew Burke, Infectious Disease and Thoracic Physician, Brisbane with presenters from Korea and Australia.

Michele Cree

PhD Candidate

UQ Centre for Clinical Research

Clinical Microsampling Group

The Clinical Microsampling Group (CMG) aims to replace traditional, highly invasive blood-taking techniques with an innovative microsampling approach that enables measuring drug concentrations in a drop of blood.

Championing research translation

Published on: 4 March 2019

National Health and Medical Research Council

The Therapeutic Drug Monitoring Group (TDMG) aims to robustly identify antimicrobial pharmacokinetic-pharmacodynamic (PK-PD) targets for use in clinical practice by better defining relationships between antimicrobial blood concentrations and outcomes.

Therapeutic drug monitoring

Respiratory Infections: Tuberculosis

Michele Cree

Clinical Microsampling Group

Championing research translation

Therapeutic Drug Monitoring

Therapeutic drug monitoring and dose personalisation of antimicrobials in mechanically ventilated patients with Gram-negative pneumonia.

Therapeutic drug monitoring optimisation of antimicrobial exposures for critically ill, burns and transplant patients.